Ocrelizumab Linked to Risk For Serious Infections in Patients With MS
CONFERENCE COVERAGE
European Committee for Treatment and Research in Multiple Sclerosis
Presenting the latest research findings from the annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis.
2025 COVERAGE
Conference Coverage from
